Supply Chain

From an unusual number of submissions of low-quality COVID-19 tests to limits at U.S. laboratories, the FDA faced multiple barriers in the early days of the COVID-19 pandemic, an HHS report found. 

From a potential cybersecurity risk for some insulin pumps to health equity issues with pulse oximeters, here are four medical device updates the FDA has published as of Sept. 15: 

Drug and medical devicemakers with operations in Puerto Rico are cautiously optimistic that Hurricane Fiona will cause few ripples across the medical supply chain.

When health systems and public health departments were scrambling to respond to the COVID-19 pandemic in early 2020, New York bought ventilators and X-ray machines for more than a quarter of a billion dollars. The products were never used and…

Pharmacies and hospitals across the country are running out of Moderna's tweaked vaccine booster, but the vaccine-maker said it expects supply to return to normal levels in a few days. 

Houston-based Texas Medical Center on Sept. 20 unveiled plans to build a biomanufacturing center called the TMC BioPort. It will focus on manufacturing and distributing medical supplies, therapies and pharmaceuticals. 

The FDA cleared the first pediatric insertable cardiac system for approval Sept. 20. 

Pharmaceutical company GSK launched a sustainable procurement program Sept. 20 in its efforts to reach net-zero impact on the climate. A big chunk of GSK's carbon emissions, 40 percent, comes from its supply chain, the company said in a news…

Medical device company Mölnlycke has opened a $49.8 million factory in Malaysia to increase production of surgical gloves. 

A growing list of drugmakers are reporting back orders for Adderall and its generics in a shortage that's been slowly worsening since August.